Sonnet biotherapeutics announces fda acceptance of the company's ind for the sb221 clinical trial of son-1010 combined with atezolizumab in the us
An ind was required to conduct the sb221 study of platinum-resistant ovarian cancer (proc) with the combination of sonnet's son-1010 and roche's atezolizumab (tecentriq ® ) in the us as part of the overall design of the program, the clinical trial was initiated at several sites in australia after hrec regulatory approval and tga notification the ind acceptance by fda allows for a global clinical effort, with the possibility for more rapid recruitment through the addition of us trial sites princeton, nj / accesswire / august 16, 2023 / sonnet biotherapeutics holdings, inc., (nasdaq:sonn) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that the ind for sb221 (nct05756907), the phase 1b/2a clinical trial of son-1010(il12-fhab) in combination with roche's anti-pd-l1 checkpoint inhibitor, atezolizumab, has been accepted, and the study can begin in the us for the treatment of proc. the trial consists of a modified 3+3 dose-escalation design in part 1 to establish the maximum tolerated dose (mtd) of son-1010 with a fixed dose of atezolizumab.
SONN Ratings Summary
SONN Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission